Ritholtz Wealth Management’s Avidity Biosciences RNAM Stock Holding History

Ritholtz Wealth Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,488	Closed	-$252K	–	1263
2025 Q4	$252K	Buy	+3,488	New	+$225K	﹤0.01%	981

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Ritholtz Wealth Management's RNAM Position: Q1 2026 in Review

Ritholtz Wealth Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,488 shares — an estimated $252K sold.

Ritholtz Wealth Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $252K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Ritholtz Wealth Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Ritholtz Wealth Management sold 3,488 Avidity Biosciences shares in Q1 2026, an estimated $252K.
Ritholtz Wealth Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Ritholtz Wealth Management's Avidity Biosciences position peaked at $252K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.